Giunio Lovel, Lozo Mislav, Borovac Josip Andelo, Bradaric Anteo, Zanchi Jaksa, Miric Dino
Clinic for Heart and Vascular Diseases, University Hospital of Split (KBC Split), Split, Croatia.
Department of Pathophysiology, School of Medicine (MEFST), University of Split, Split, Croatia.
Postepy Kardiol Interwencyjnej. 2021 Dec;17(4):389-397. doi: 10.5114/aic.2021.112081. Epub 2021 Dec 29.
Proximal venous approaches (femoral or jugular) for catheter-directed thrombolysis (CDT) of acute pulmonary embolism (PE) dominate in clinical practice.
We investigated the feasibility and safety of CDT in acute PE by using the superficial cubital venous approach.
All patients with acute PE received intravenous unfractionated heparin plus CDT. CDT included mechanical thrombus fragmentation and the local application of adjuvant thrombolytic therapy through the pigtail catheter - alteplase administered as 2.5 mg bolus in each main branch of the pulmonary artery plus adjuvant 25 mg for 12 h in the more severely affected branch of the pulmonary artery.
Twenty-seven consecutive patients presenting with acute massive (high risk) PE ( = 10) or submassive (intermediate risk) PE ( = 17) were enrolled in the study. The mean age of the enrolled cohort was 60.6 (14.1) years and most patients were female ( = 14, 52%). The procedural success of CDT application through the cubital vein was achieved in all patients. After the procedure, the systolic pulmonary artery pressure decreased from 61.4 (18.3) to 35.8 (12.3) mm Hg ( < 0.001) while the mean pulmonary artery pressure decreased from 35.7 (10.8) to 21.1 (6.5) mm Hg ( < 0.001). Similarly, the mean arterial pressure increased from 81.9 (12.8) to 89.0 (10.3) mm Hg ( = 0.031). Miller angiographic obstruction score and Miller index decreased significantly after the CDT intervention ( < 0.001). There were no deaths, major bleeding events, or hemorrhagic strokes.
CDT by using the cubital approach is a simple, safe, and feasible treatment option for PE. This approach was associated with significant improvement in hemodynamic parameters without fatal outcomes or major periprocedural complications.
在临床实践中,急性肺栓塞(PE)导管直接溶栓(CDT)的近端静脉途径(股静脉或颈静脉)占主导地位。
我们研究了采用肘浅静脉途径进行急性PE的CDT的可行性和安全性。
所有急性PE患者均接受静脉普通肝素加CDT治疗。CDT包括机械性血栓破碎以及通过猪尾导管局部应用辅助溶栓治疗——在肺动脉的每个主要分支中给予2.5mg阿替普酶推注,并在肺动脉受影响更严重的分支中给予25mg辅助剂量,持续12小时。
连续27例急性大面积(高危)PE(n = 10)或次大面积(中危)PE(n = 17)患者纳入研究。纳入队列的平均年龄为60.6(14.1)岁,大多数患者为女性(n = 14,52%)。所有患者通过肘静脉进行CDT应用均获得了手术成功。术后,收缩期肺动脉压从61.4(18.3)降至35.8(12.3)mmHg(P < 0.001),而平均肺动脉压从35.7(10.8)降至21.1(6.5)mmHg(P < 0.001)。同样,平均动脉压从81.9(12.8)升至89.0(10.3)mmHg(P = 0.031)。CDT干预后,米勒血管造影阻塞评分和米勒指数显著降低(P < 0.001)。未发生死亡、重大出血事件或出血性卒中。
采用肘静脉途径的CDT是一种简单、安全且可行的PE治疗选择。该途径与血流动力学参数的显著改善相关,且无致命后果或重大围手术期并发症。